Lori is a seasoned executive leader at a Fortune 10 company with more than 25 years of experience advising public companies on business strategy, risk management, and reputational issues.
Lori currently serves as Executive Vice President, Chief Legal Officer, and General Counsel of McKesson Corporation (NYSE: MCK), a U.S. publicly-traded diversified healthcare services company with revenues of $277B in fiscal year 2023 and a current market cap of $57B. In this role, she is responsible for overseeing 500+ employees in departments beyond legal, including public affairs, compliance, quality, brand, marketing & communications, and the Corporate Secretary for the company’s board of directors.
At McKesson, Lori spearheaded the transformation of the company’s Impact Report, its risk management program and annual risk assessment process, as well as its crisis preparedness plans and protocols for senior executives and the board. She works closely with the board on strategic priorities, governance matters, risk management, ESG, and addressing cybersecurity and shareholder activism. Under her leadership, the company formalized a pro bono and volunteer program to support communities across the country, as well as an advocacy ambassador program to enhance the dialogue between McKesson and U.S. Congressional offices on issues of importance to the company.
Prior to becoming Chief Legal Officer and General Counsel of McKesson in 2014, Lori served as Associate General Counsel of McKesson from January 2012 to June 2014. Previously, she was a litigation partner at Morrison & Foerster, an international law firm, where she represented clients in complex litigation and investigations. Lori served for four years as chair of the firm’s 500-lawyer global litigation department.
Throughout her career, Lori has led and addressed complex matters in response to and in partnership with government entities. Lori navigated the impact of the national opioid crisis for McKesson, addressing the government-entity and private party litigation landscape, complex and novel legal theories, and the reputational microscope from politicians, shareholders, and the public. She helped turn challenges into opportunities and partnerships with carefully directed government entity settlements and the formation of a private foundation, both focused on critical response efforts to address the epidemic. Lori and the teams she leads also helped ensure McKesson’s successful partnership with the U.S. government in its role as the sole distributor selected to deliver COVID-19 vaccines nationwide.
Lori’s leadership accomplishments were recognized in 2022 when she received a Burton Award at the Library of Congress based on her demonstrated track record of addressing complex matters of national or global significance in a specialized area.
Board Service & Education
Lori served on the Supervisory Board of McKesson Europe, responsible for overseeing business strategy, risk management, acquisitions, and its 2022 divestiture. She also currently serves on the boards of the following non-profit organizations: National Center for Youth Law (member of the Governance Committee) and the Foundation for Opioid Response Efforts (chair of the Governance Committee). Lori received her B.A. from Cornell University and her J.D. from Yale Law School.